B. Riley Financial, Inc. Pfizer Inc Transaction History

B. Riley Financial, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $198,120 - $225,879	-5,150 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $413,088 - $501,051	-11,984 Reduced 69.94%	5,150 $227,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $105,008 - $111,949	-3,184 Reduced 15.67%	17,134 $636,000
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $103,196 - $119,722	3,234 Added 18.93%	20,318 $721,000
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $69,380 - $73,614	-2,086 Reduced 10.88%	17,084 $619,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $594,270 - $654,655	19,170	19,170 $684,000

3,273

3.72B

77.2M

123M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.